Related Articles
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer Retraction in /10.3892/ol.2021.13061
SOCS4 expressed by recombinant HSV protects against cytokine storm in a mouse model
Oncolytic recombinant herpes simplex virus for treatment of orthotopic liver tumors in nude mice
Evaluation of HSV-1 and adenovirus vector-mediated infection, replication and cytotoxicity in lymphoma cell lines
Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer